D.E. Shaw & Co — VRTX Trade History
Quarter-by-quarter changes in the VERTEX PHARMACEUTICALS INC position · CUSIP 92532F100
Currently held · 2 QFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 3,105 | -245,855 | -98.8% | $1.5M | 0.00% |
| 2026 Q1 | 2026-05-15 | New | 248,960 | 248,960 | — | $111.2M | 0.07% |
| 2025 Q4 | 2026-02-17 | Sold out | — | -3,343 | -100.0% | — | — |
| 2025 Q3 | 2025-11-14 | Reduce | 3,343 | -16,738 | -83.4% | $1.3M | 0.00% |
| 2025 Q2 | 2025-08-14 | Reduce | 20,081 | -51,852 | -72.1% | $8.9M | 0.01% |
| 2025 Q1 | 2025-05-15 | Reduce | 71,933 | -193,751 | -72.9% | $34.9M | 0.03% |
| 2024 Q4 | 2025-02-14 | Add | 265,684 | 127,276 | +92.0% | $107.0M | 0.08% |
| 2024 Q3 | 2024-11-14 | New | 138,408 | 138,408 | — | $64.4M | 0.06% |
| 2024 Q1 | 2024-11-14 | — | — | — | — | — | — |
| 2023 Q4 | 2024-11-14 | Sold out | — | -170,063 | -100.0% | — | — |
| 2024 Q2 | 2024-08-14 | Reduce | 170,063 | -86,930 | -33.8% | $79.7M | 0.07% |
| 2023 Q3 | 2023-11-14 | Add | 256,993 | 5,235 | +2.1% | $89.4M | 0.09% |
| 2023 Q2 | 2023-08-14 | Add | 251,758 | 46,826 | +22.8% | $88.6M | 0.09% |
| 2023 Q1 | 2023-05-15 | Add | 204,932 | 94,399 | +85.4% | $64.6M | 0.07% |
| 2022 Q4 | 2023-02-14 | Reduce | 110,533 | -7,720 | -6.5% | $31.9M | 0.04% |
| 2022 Q3 | 2022-11-14 | Reduce | 118,253 | -160,491 | -57.6% | $34.2M | 0.04% |
| 2022 Q2 | 2022-08-15 | Reduce | 278,744 | -465,504 | -62.5% | $78.5M | 0.09% |
| 2022 Q1 | 2022-05-16 | Reduce | 744,248 | -277,075 | -27.1% | $194.2M | 0.18% |
| 2021 Q4 | 2022-02-14 | Reduce | 1,021,323 | -693,311 | -40.4% | $224.3M | 0.19% |
| 2021 Q3 | 2021-11-15 | Add | 1,714,634 | 937,619 | +120.7% | $311.0M | 0.28% |
| 2021 Q2 | 2021-08-16 | Add | 777,015 | 230,391 | +42.1% | $156.7M | 0.14% |
| 2021 Q1 | 2021-05-17 | Reduce | 546,624 | -327,724 | -37.5% | $117.5M | 0.11% |
| 2020 Q4 | 2021-02-16 | Add | 874,348 | 523,210 | +149.0% | $206.6M | 0.18% |
| 2020 Q3 | 2020-11-16 | Add | 351,138 | 203,308 | +137.5% | $95.6M | 0.10% |
| 2020 Q2 | 2020-08-14 | Reduce | 147,830 | -149,357 | -50.3% | $42.9M | 0.05% |
| 2020 Q1 | 2020-05-15 | Reduce | 297,187 | -76,786 | -20.5% | $70.7M | 0.11% |
| 2019 Q4 | 2020-02-14 | Reduce | 373,973 | -324,695 | -46.5% | $81.9M | 0.09% |
| 2019 Q3 | 2019-11-14 | Reduce | 698,668 | -171,241 | -19.7% | $118.4M | 0.15% |
| 2019 Q2 | 2019-08-14 | Reduce | 869,909 | -133,320 | -13.3% | $159.5M | 0.20% |
| 2019 Q1 | 2019-05-15 | Reduce | 1,003,229 | -165,372 | -14.2% | $184.5M | 0.24% |
| 2018 Q4 | 2019-02-14 | Reduce | 1,168,601 | -96,755 | -7.6% | $193.6M | 0.27% |
| 2018 Q3 | 2018-11-14 | Add | 1,265,356 | 163,766 | +14.9% | $243.9M | 0.29% |
| 2018 Q2 | 2018-08-14 | Add | 1,101,590 | 142,529 | +14.9% | $187.2M | 0.24% |
| 2018 Q1 | 2018-05-15 | Add | 959,061 | 539,411 | +128.5% | $156.3M | 0.21% |
| 2017 Q4 | 2018-02-14 | Add | 419,650 | 95,561 | +29.5% | $62.9M | 0.09% |
| 2017 Q3 | 2017-11-14 | Reduce | 324,089 | -484,897 | -59.9% | $49.3M | 0.08% |
| 2017 Q2 | 2017-08-14 | Add | 808,986 | 234,501 | +40.8% | $104.3M | 0.17% |
| 2017 Q1 | 2017-05-15 | Reduce | 574,485 | -63,098 | -9.9% | $62.8M | 0.11% |
| 2016 Q4 | 2017-02-14 | Add | 637,583 | 189,572 | +42.3% | $47.0M | 0.08% |
| 2016 Q3 | 2016-11-14 | New | 448,011 | 448,011 | — | $39.1M | 0.07% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.